Highlander Capital Management’s iShares Biotechnology ETF IBB Stock Holding History

Highlander Capital Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-60	Closed	-$6K	–	704
2018 Q4	$6K	Hold	60	–	–	﹤0.01%	595
2018 Q3	$7K	Hold	60	–	–	﹤0.01%	622
2018 Q2	$7K	Hold	60	–	–	﹤0.01%	639
2018 Q1	$6K	Hold	60	–	–	﹤0.01%	647
2017 Q4	$6K	Hold	60	–	–	﹤0.01%	641
2017 Q3	$7K	Hold	60	–	–	0.01%	634
2017 Q2	$6K	Hold	60	–	–	﹤0.01%	652
2017 Q1	$6K	Hold	60	–	–	﹤0.01%	657
2016 Q4	$5K	Buy	+60	New	+$5.46K	﹤0.01%	677

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

DFO

Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return

Highlander Capital Management's IBB Position: Q1 2019 in Review

Highlander Capital Management sold out of iShares Biotechnology ETF (IBB) in Q1 2019, closing a stake of 60 shares — an estimated $6K sold.

Highlander Capital Management first reported a position in IBB in Q4 2016 and held it in 9 quarters. The position peaked at $7K in Q3 2018. 670 funds tracked by Wall St. Rank hold IBB as of Q1 2019.

Highlander Capital Management reported no remaining iShares Biotechnology ETF position as of Q1 2019 after selling out during the quarter.
Highlander Capital Management sold 60 iShares Biotechnology ETF shares in Q1 2019, an estimated $6K.
Highlander Capital Management first reported a position in iShares Biotechnology ETF in Q4 2016 and held it in 9 quarters.
Highlander Capital Management's iShares Biotechnology ETF position peaked at $7K in Q3 2018.
670 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2019.

Based on Highlander Capital Management's 13F filing for Q1 2019, filed 15 May 2019.